Co-Diagnostics Inc (CODX) Stock Analysis
Verdict: AVOID
Extreme parabolic price action on negligible fundamental news masks a terminal revenue decline and a 5-month cash runway.
Investment score: 22/100
Analysis as of
Is Co-Diagnostics Inc stock worth reviewing? AI model thesis
Avoid CODX due to extreme financial distress and unsustainable technical exhaustion.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 30/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 10/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Co-Diagnostics Inc opportunities and risks
What speaks for CODX
- Co-Dx PCR Platform Commercialization
What speaks against CODX
- Imminent Cash Exhaustion
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CODX | n/a | 14.2x | n/a | 9.5% | -6753.7% | -285.1% |
| MYO | n/a | 1.0x | n/a | 66.0% | -36.7% | -43.6% |
| VASO | 23.0x | 0.5x | n/a | 61.7% | 2.0% | -9.3% |
| RDGL | n/a | 443.0x | n/a | -275.6% | -4396.3% | -6.6% |
| NMTC | n/a | 3.4x | n/a | 54.5% | -68.3% | -22.7% |
| MLSS | n/a | 3.7x | n/a | 70.4% | -51.3% | -5.6% |
| Peer median | n/a | 3.4x | n/a | 61.7% | -51.3% | -9.3% |
Frequently asked questions about Co-Diagnostics Inc (CODX)
Is CODX stock a good investment?
The cached TradeMates AI model rates Co-Diagnostics Inc as AVOID with an investment score of 22/100. Avoid CODX due to extreme financial distress and unsustainable technical exhaustion. This is algorithmic model output, not personal investment advice.
Is CODX stock a buy?
The TradeMates model verdict for CODX is AVOID with an investment score of 22/100. Treat this as a model signal to review, not a personal buy recommendation.